Proteomics Market Trends Support A 13.2% CAGR Outlook Through The Forecast Period

Proteomics is rapidly emerging as a critical field in life sciences, driven by technological advances and increasing applications in medicine and research. As the market evolves, new innovations and strategic acquisitions are shaping its future trajectory, highlighting its growing significance in precision healthcare and biological analysis.

Proteomics Market Size and Growth Outlook Through 2030
The proteomics market is on track for substantial expansion, projected to reach $73.33 billion by 2030. This growth corresponds to a strong compound annual growth rate (CAGR) of 13.2%. Key factors propelling this increase include heightened investments in precision medicine, expanding uses of multi-omics approaches, broader clinical applications of proteomics, rising adoption of AI-powered data analytics, and a deeper focus on understanding disease pathways. Leading trends anticipated during this period involve the widespread uptake of advanced proteomic techniques, enhanced mass spectrometry applications, tighter integration of proteomics with genomic data, growth in cloud-based proteomics solutions, and an increased emphasis on quantitative proteomic methods.

The proteomics market size has grown rapidly in recent years. It will grow from $39.37 billion in 2025 to $44.65 billion in 2026 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to expansion of life sciences research funding, increasing use of proteomics in drug discovery, availability of high-performance analytical instruments, growth of academic research programs, rising demand for biomarker discovery.

Download a free sample of the proteomics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2828&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

The Main Organizations Driving the Proteomics Market Forward
A range of prominent companies dominate the proteomics landscape, including Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Bruker Corporation, and Bio-Rad Laboratories Inc. Other key players include Promega Corporation, Waters Corporation, Creative Proteomics, Sino Biological, EIAab, DIMA Biotechnology, GE Healthcare, Perseus Proteomics Inc., JEOL, APTBIO, Vproteomics, Shimadzu Corporation, Abcam plc, MRM Proteomics Inc., Biognosys AG, Olink Proteomics, Horiba, MS Bioworks, LC Sciences, MtoZ Biolabs, Integrated Proteomics Applications, Quantumbio Inc., Luminex Corporation, Applied Biomics Inc., Isoplexis Corporation, and Caprion Proteomics Inc.

Significant Acquisition Highlighting Market Consolidation
In July 2024, Thermo Fisher Scientific, a leading US-based life sciences company, acquired Sweden-based Olink Holding for roughly $3.1 billion. This strategic move aims to strengthen Thermo Fisher's array of cutting-edge technologies. Olink's proprietary Proximity Extension Assay (PEA) technology facilitates high-throughput protein analysis using quantitative polymerase chain reaction and next-generation sequencing readout systems. With access to a library exceeding 5,300 validated protein biomarker targets, Thermo Fisher is poised to enhance its capabilities significantly in proteomics research.

View the full proteomics market report:
https://www.thebusinessresearchcompany.com/report/proteomics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Emerging Trends Steering Innovation in the Proteomics Industry
Industry participants are concentrating on creating highly precise quantitative analysis kits to maintain a competitive edge. These kits enable accurate measurement of protein expression and biomarker detection across various biological samples. For example, in January 2023, SCIEX, a US-based mass spectrometry instrument manufacturer, launched the Fast Glycan Labeling and Analysis kit. This product supports detailed quantitative glycan analysis and complements an update to their Biologics Explorer software, which streamlines workflows related to protein therapeutics analysis. These innovations empower researchers with advanced tools for more comprehensive biopharmaceutical investigations and help optimize analytical workflows for better decision-making.

Proteomics Market Segmentation and Forecast Insights
The proteomics market is divided into several important segments:
1) By Component: Reagents, Instruments, Software
2) By Instrument Type: Protein Microarrays, Spectroscopy, X-ray Crystallography, Chromatography, Electrophoresis, Surface Plasmon Resonance, Protein Fractionation
3) By Service Type: Core Instrument Services, Proteomic Analytical Services

Further subsegments include:
1) Reagents: Protein Assays, Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Electrophoresis Reagents
2) Instruments: Mass Spectrometry, Chromatography Equipment, Electrophoresis Equipment, Microarray Instruments, X-ray Crystallography Instruments
3) Software: Data Analysis Software, Bioinformatics Tools, Cloud-Based Platforms for Proteomics

This detailed breakdown highlights the diversity within the proteomics market, catering to the wide-ranging needs of researchers and clinicians globally.

Key enhancements in our 2026 market reports include:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.